All News

lupus,nephritis,GN

Tacrolimus Measures Up in Lupus Nephritis Trial

d MedPage Today

In a phase III trial, oral tacrolimus (Prograf) proved non-inferior to intravenous cyclophosphamide for treating lupus nephritis, researchers said.

Read Article
virus,injection,COVID,vaccine

FDA Authorizes 2nd Booster for Older and Immunocompromised Individuals

d FDA

Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

Read Article
Psoriasis Severe legs sara

Differences in Biologic Persistence in Psoriasis and Psoriatic Arthritis

d Jack Cush, MD

Administrative claims analysis of biologic use in psoriasis (PsO) and psoriatic arthritis (PsA) in French health insurance databases shows that despite widespread biologic use, overall drug persistence (beyond 3 years) was low for PsO and PsA biologics.

Read Article
alopecia,areata,bald,hairloss

Baricitinib Efficacy in Alopecia Areata

d Jack Cush, MD

The NEJM has published the results of the BRAVE-AA1 and BRAVE-AA2 trials, demonstrating that baricitinib is effective at regrowing hair in alopecia areata (AA) patients, thus paving the way for future regulatory approval for this difficult to treat disorder. 

Read Article
Join us for Tuesday Night Rheumatology on April 5 at 7pm ET. Register today! https://t.co/ocaWwqB51x https://t.co/IPsf45UV0V

Links:

Dr. John Cush RheumNow ( View Tweet)
Differences in Biologic Persistence in PsO and PsA Administrative claims analysis of biologic use in PsO and PsA in French health insurance databases shows that despite widespread biologic use, overall drug persistence was low for PsO and PsA biologics. https://t.co/PtrXu9xyFa https://t.co/RWciF4DqXj

Links:

Dr. John Cush RheumNow ( View Tweet)
Metanalysis of 51 studies shows that chronic noninflammatory MSK pain is associated with impaired sexual function; compromised intimate relationships; and issues of sexual identity, body image, and self-worth https://t.co/VKHEMWiQZb https://t.co/OXhNSQF8Vc

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of 119 SLE pts (30 w CKD) shows urinary galectin-3 binding protein as a biomarker, increased w/ active LN, significantly (p<0.001)correlating w/ SLEDAI, SLICC RAS, histologic activity; higher in proliferative vs membranous LN (p=0.04) https://t.co/s8mRnfxIj6 https://t.co/s1OoiRy6Xi

Links:

Dr. John Cush RheumNow ( View Tweet)
Adipokines are associated with CHF hospitalization (HR 1.39) & CVD-related death (HR 1.49) in #RA pts, especially in non-obese RA. This includes High leptin assoc w/ CV-death (HR 1.44) and High FGF-21 w/ lower CAD (HR 0.75) https://t.co/GQx1kzFOIJ https://t.co/M6MF73xPYs

Links:

Dr. John Cush RheumNow ( View Tweet)
Mark your calendars! RheumNow is covering PsA this April. That means more Therapeutic Updates, Tuesday Night Rheumatology, Expert Blogs, and more. Join us April 1-30. https://t.co/b6OgsR8uxL
Dr. John Cush RheumNow ( View Tweet)
A case–control study from Kaiser, compared obstetric complications in women who later developed Systemic Sclerosis (n=17) vs non-SSc controls (170). Obstetric complications higher in later SSc (71 v 50%) (HTN, PROM, IUGR, NICU, preterm births) https://t.co/4Y4eGuCFJi https://t.co/R4vw90bba4

Links:

Dr. John Cush RheumNow ( View Tweet)
Infection in lupus is suggested by very high CRP, PMN-lymph ratio (NLR) Plt-lymph ratio(PLR). Study of 104 hospitalized SLE found all very high w/ infx & Combined cutoffs of CRP >20 mg/L, NLR >3.5, PLR >151 had 87 sensitivity & 81% specificity for infx https://t.co/5SjFsrBiZp https://t.co/0Ipussd9fF

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Montreal General Hosp SLE cohort study of 489 SLE pts - 35% have Raynauds phenomena; RP in SLE assoc. w/ Female (OR 2.43), White (OR 1.85), CNS disease (OR 1.98), RNP Abs (OR 3.0); negatively assoc w/ hemolytic anemia & cellular casts https://t.co/5t3GL4jqrm https://t.co/gVVqccvtca

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Environmental Pollutants Ups Autoimmune Disease Risk An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, CTDs and inflammatory bowel diseases (IBD). https://t.co/oKdgSZ2jAF https://t.co/WI7aShKR97

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast available on Lupus worries. Download wherever you get your podcasts. https://t.co/gU1mmRXYUi https://t.co/54IDshqNYd

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Effect of Intraarticular Steroid Shots on Knee OA Outcomes In patients w/ OA of the knee, intra-articular injections of steroids didn’t increase rates of either disease progression or subsequent knee replacement surgery, researchers said. https://t.co/qinnfFLsGQ https://t.co/6859pSNNhL

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Drugs for Pregnancy Hopefuls A Young Woman has uncontrolled RA, but wants to get pregnant. What do you chose? https://t.co/Sunx8RWRfM https://t.co/hsFNhVfwHd

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis https://t.co/q0uIjLrT3G https://t.co/ehgEUSrbPg

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Swedish study found 1774 systemic sclerosis (SSc) pts in 2015 w/ median age 65 yrs (84% women) = prevalence=22.7 per 100,000 . Incidence (2004-2015) was 11.9 per 1,000,000 PYs - incidence remained stable; F were 5x more common than M. https://t.co/NPZUg4CEjA https://t.co/V3H381KpHU

Links:

Dr. John Cush RheumNow ( View Tweet)
Ask Cush Anything! Have a rheumatology question or case for Dr. Cush? Submit it here and we may feature it on an upcoming podcast. https://t.co/KgPIeScthr https://t.co/nk4re9mlcH

Links:

Dr. John Cush RheumNow ( View Tweet)
×